China almost instantly fired back at the United States after President Donald Trump's 10% tariff on goods from China came into effect, announcing it was imposing counter-tariffs on some US products starting February 10.Beijing said it would hit the US with a 15% tariff on coal and liquified natural...
The European Commission announced on Thursday its demand from Illumina Inc. to undo its acquisition of the biotechnological company GRAIL despite the process already being completed.
According to its written statement, the commission found the deal to be unlawful as it would have "stifled...
Shares of American biotechnology firm Illumina Inc. slid 4% on Friday after revealing that the United States Securities and Exchange Commission (SEC) launched a probe into its $8 billion acquisition agreement with Grail.
Namely, the SEC informed Illumina back in July about the investigation,...
The European Commission announced Wednesday it had fined Illumina and GRAIL around €432 million and €1 billion, respectively, for implementing their acquisition without prior merger control clearance.
"If companies merge before our clearance, they breach our rules. Illumina and GRAIL...
The United States Federal Trade Commission announced on Monday that it opposes the $7.1 billion acquisition of Grail Inc. by Illumina Inc. and ordered the two companies to remain separate businesses.
The deal would "stifle competition and innovation in the US market for life-saving cancer tests" as...
European Union antitrust regulators blocked on Tuesday Illumina's proposed acquisition of Grail worth $8 billion, noting the merger would have "stifled innovation, and reduced choice in the emerging market for blood-based early cancer detection tests."
European Commission Executive Vice-President...
Illumina, Inc. announced on Monday it reached an agreement to acquire Grail for $8 billion, confirming earlier media reports.
The transaction, which will see Grail stockholders, including Illumina, receive a total of $3.5 billion in cash and $4.5 billion in Illumina common stock, has been approved by...
Illumina Inc. is looking to acquire Grail Inc. for $7.1 billion, the Wall Street Journal reported on Monday. The company is already a partial owner of Grail, a gene-sequencing company, and is now planning to buy the rest of the stake with $3.1 billion in cash and $4 billion in shares.
The acquisition would...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
